Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 30Central Nervous System Neoplasms 18Rectal Neoplasms 15Colorectal Neoplasms 15Lung Neoplasms 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Stomach Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Gliosarcoma 7Neoplasm Metastasis 6Esophageal Neoplasms 6Brain Neoplasms 6Adenocarcinoma Of Esophagus 6Carcinoma, Intraductal, Noninfiltrating 5Breast Neoplasms, Male 5Breast Carcinoma In Situ 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Mesothelioma, Malignant 4Kidney Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Solitary Fibrous Tumor, Pleural 3Prostatic Neoplasms 3Ovarian Neoplasms 3

Interventions

Amifostine 10Cisplatin 8Radiotherapy 7Etoposide 6Cyclophosphamide 4Carboplatin 4Paclitaxel 3pegfilgrastim 2camrelizumab 2apatinib 2Mitoxantrone 2Filgrastim 2Drug Therapy 2Cytarabine 2sodium thiosulfate 1sargramostim 1pazopanib 1icotinib 1glucarpidase 1etoposide phosphate 1denileukin diftitox 1Vitamin E 1Triptorelin Pamoate 1Tocopherols 1Thiotepa 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Silymarin 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Drug-Related Side Effects and Adverse Reactions × Chemotherapy, Adjuvant × Clear all
NCT00006105 2013-09-05

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

University of Chicago

Phase 2 Completed
37 enrolled
Genitourinary

Urinary Bladder Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡